ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: AMOS Says Cancer Program Should Not Have Ceiling Of $1 Billion; OSHA Drops Effort To Fire Infants

August 14, 1981

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

New Research Grant Awards

December 13, 1974

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979